ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

228
Analysis
Health Care • Japan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
•29 Mar 2018 14:03

Japan Pharmaceutical - Sector Overview

Core coverage – relative valuations Takeda Pharmaceutical Co Ltd (4502 JP) (NB: Pre-Shire announcement | Pro-Forma analysis to be published...

bearish•Fast Retailing
•12 Feb 2018 08:14

Trading the BOJ-Nikkei 225 Baskets

One week ago in The BOJ's Ongoing ETF Impact - Is a Nikkei 225 Reshuffle in the Cards? I discussed the BOJ's past and current ETF purchasing...

Logo
628 Views
Share
bearish•Fast Retailing
•04 Feb 2018 14:29

The BOJ's Ongoing ETF Impact - Is a Nikkei 225 Reshuffle in the Cards?

Just over six months ago, a breathless article on Bloomberg noted that according to their calculations, the BOJ owned 71% of the ETFs in the...

Logo
1.8k Views
Share
bullish•Celltrion Inc
•04 Feb 2018 00:10

Last Week in Event SPACE - Astellas, Celltrion, Renesas, AWE, Viva, Kushikatsu

Last week, Astellas Pharma Inc (4503 JP)'s latest buyback may impact the stock; KOSDAQ 150 names expected to benefit as Celltrion Inc (068270 KS)...

Logo
417 Views
Share
bullish•Astellas Pharma
•31 Jan 2018 19:45

Astellas (4503 JP) Buyback - How It Stacks Up Against Past Buybacks

A small note about the buyback. There is more here than meets the eye.Today, Astellas Pharma Inc (4503 JP)announced a buyback program to repurchase...

Logo
365 Views
Share
x